Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medical Strategy is a specialized investment management firm focused on the global healthcare and biotechnology sectors. Based in Gräfelfing, Germany, the company is best known for managing the Medical BioHealth fund (formerly Medical BioHealth-Trends), which invests in innovative small and mid-cap biotech and pharmaceutical companies. The firm's investment philosophy is rooted in scientific and medical analysis, utilizing a team of experts including MDs and PhDs to evaluate clinical data and identify companies with the potential to transform patient care. Medical Strategy has received numerous awards for its fund performance and is recognized as a leading authority in healthcare equity investing. The company's portfolio typically includes high-growth firms in therapeutic areas such as oncology, rare diseases, and gene therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medical BioHealth-Trends.